Trends in Secondary Antibiotic Resistance of Helicobacter pylori from 2007 to 2014: Has the Tide Turned?

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

(2013) David Y. Graham et al.   Clinical Gastroenterology and Hepatology

Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment ofHelicobacter pyloriInfection

(2013) Marino Venerito et al.   DIGESTION

Helicobacter pylorieradication in Western Australia using novel quadruple therapy combinations

(2012) C. Y. Tay et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Resistance rates of metronidazole and other antibacterials inHelicobacter pylorifrom previously untreated patients in Norway

(2012) Astri L. Larsen et al.   APMIS

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Detection of Clarithromycin-ResistantHelicobacter pyloriby Stool PCR in Children: A Comprehensive Review of Literature

(2012) Li jing Xiong et al.   HELICOBACTER

Trends in outpatient antibiotic use in Israel during the years 2000–2010: setting targets for an intervention

(2012) M. Low et al.   INFECTION

Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen

(2012) Mario M D'Elios et al.   Expert Review of Gastroenterology & Hepatology

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori

(2011) P Patrick Basu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Seroprevalence, correlates and trends of Helicobacter pylori infection in the Israeli population

(2011) K. MUHSEN et al.   EPIDEMIOLOGY AND INFECTION

European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009)

(2011) et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multicenter Survey of Routine Determinations of Resistance of Helicobacter pylori to Antimicrobials over the Last 20 Years (1990 to 2009) in Belgium

(2011) V. Y. Miendje Deyi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Two-decade trends in primary Helicobacter pylori resistance to antibiotics in Bulgaria

(2010) Lyudmila Boyanova et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China

(2010) Wen Gao et al.   HELICOBACTER

High Level of Antimicrobial Resistance in FrenchHelicobacter pyloriIsolates

(2010) Josette Raymond et al.   HELICOBACTER

Variability in Outpatient Antimicrobial Consumption in Israel

(2010) O. Nitzan et al.   INFECTION

High Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains and Risk Factors Associated with Resistance in Madrid, Spain

(2010) S. Agudo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antibiotic resistance ofHelicobacter pyloriin Israeli children

(2010) Noam Zevit et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005

(2009) James A. Karlowsky et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS